FDA Sends 100 Cease-and-Desist Letters in Crackdown on DTC Drug Advertisements

FDA sends 100 cease-and-desist letters in crackdown on DTC drug advertisements

The U.S. Food and Drug Administration is taking new steps to regulate direct-to-consumer drug advertisements and eliminate misleading advertisements out of concern that patients are not receiving a "fair balance" of information on pharmaceutical products.

FDA sends 100 cease-and-desist letters in crackdown on DTC drug advertisements – RamaOnHealthcare

The U.S. Food and Drug Administration is taking new steps to regulate direct-to-consumer drug advertisements and eliminate misleading advertisements out of concern that patients are not receiving a "fair balance" of information on pharmaceutical products."For far too long, the FDA has permitted misleading drug advertisements, distorting the doctor-patient relationship and creating increased demand for medications [...]

FDA Issues Around 100 Warning Letters to Drug Advertisers Including Hims & Hers Over Advertising Violations

The Food and Drug Administration (F.D.A.) issued approx […]